Sisältöön
tampereen yliopisto: lääketieteen ja biotieteiden tiedekunta: julkaisut:
Lääketieteen ja biotieteiden tiedekuntaTampereen yliopisto BioMediTech

IBT julkaisut 2000

NOTE: This list is not exhaustive because it has been collected by an automatic procedure from PubMed. It may also contain publications not related to IMT or Regea authors (authors having the same name). The same publication may also appear more than once in case several research groups have participated in the writing.
Vihinen M, Lehvaslaiho H
[Genetic databases and their use]
Duodecim 2000 ;116(16)1759-62
PMID

Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Perez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF
Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
Immunol Rev 2000 ;17839-48
PMID

Valiaho J, Riikonen P, Vihinen M
Novel immunodeficiency data servers.
Immunol Rev 2000 ;178177-85
PMID

Siermala M, Juhola M, Vihinen M
Neural network prediction of polyproline type II secondary structures.
Stud Health Technol Inform 2000 ;77475-9
PMID

Mattsson PT, Lappalainen I, Backesjo CM, Brockmann E, Lauren S, Vihinen M, Smith CI
Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
J Immunol 2000 ;164(8)4170-7
PMID

Rong SB, Vihinen M
Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain.
J Mol Med 2000 ;78(9)530-7
PMID

Vihinen M, Mattsson PT, Smith CI
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Front Biosci 2000 ;5D917-28
PMID

Nera KP, Brockmann E, Vihinen M, Smith CI, Mattsson PT
Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies.
Protein Expr Purif 2000 ;20(3)365-71
PMID

Lindfors K, Halttunen T, Huotari P, Nupponen N, Vihinen M, Visakorpi T, Maki M, Kainulainen H
Identification of novel transcription factor-like gene from human intestinal cells.
Biochem Biophys Res Commun 2000 ;276(2)660-6
PMID

Korpi M, Valiaho J, Vihinen M
Structure-function effects in primary immunodeficiencies.
Scand J Immunol 2000 ;52(3)226-32
PMID

Rong SB, Valiaho J, Vihinen M
Structural basis of Bloom syndrome (BS) causing mutations in the BLM helicase domain.
Mol Med 2000 ;6(3)155-64
PMID

Vihinen M, Villa A, Mella P, Schumacher RF, Savoldi G, O'Shea JJ, Candotti F, Notarangelo LD
Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
Clin Immunol 2000 ;96(2)108-18
PMID

Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K, Antonarakis SE, Shimizu N, Kudoh J, Peterson P
Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family.
Genomics 2000 ;65(3)293-8
PMID

Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P
The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein.
J Biol Chem 2000 ;275(22)16802-9
PMID

Lappalainen I, Giliani S, Franceschini R, Bonnefoy JY, Duckett C, Notarangelo LD, Vihinen M
Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
Biochem Biophys Res Commun 2000 ;269(1)124-30
PMID

Stenberg KA, Riikonen PT, Vihinen M
KinMutBase, a database of human disease-causing protein kinase mutations.
Nucleic Acids Res 2000 ;28(1)369-71
PMID

Isola J, Järvinen T, Tanner M, Holli K
[HER-2/neu oncogene in the selection of treatment for breast cancer and as a target of immunotherapy].
Duodecim 2000 ;116(15)1538-46
PMID

Miettinen HE, Järvinen TA, Kellner U, Kauraniemi P, Parwaresch R, Rantala I, Kalimo H, Paljärvi L, Isola J, Haapasalo H
High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
Neuropathol Appl Neurobiol 2000 ;26(6)504-12
PMID

Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.
Am J Pathol 2000 ;157(5)1467-72
PMID

Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J, Borg A
MYB oncogene amplification in hereditary BRCA1 breast cancer.
Cancer Res 2000 ;60(19)5323-8
PMID

Kytölä S, Farnebo F, Obara T, Isola J, Grimelius L, Farnebo LO, Sandelin K, Larsson C
Patterns of chromosomal imbalances in parathyroid carcinomas.
Am J Pathol 2000 ;157(2)579-86
PMID

Staff S, Nupponen NN, Borg A, Isola JJ, Tanner MM
Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
Genes Chromosomes Cancer 2000 ;28(4)432-42
PMID

Kytölä S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.
Genes Chromosomes Cancer 2000 ;28(3)308-17
PMID

Nupponen NN, Isola J, Visakorpi T
Mapping the amplification of EIF3S3 in breast and prostate cancer.
Genes Chromosomes Cancer 2000 ;28(2)203-10
PMID

Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ
Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
Clin Cancer Res 2000 ;6(5)1833-9
PMID

Borg A, Isola J, Chen J, Rubio C, Johansson U, Werelius B, Lindblom A
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma.
Int J Cancer 2000 ;85(6)796-800
PMID

Järvinen TA, Tanner M, Rantanen V, Bärlund M, Borg A, Grénman S, Isola J
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Am J Pathol 2000 ;156(3)839-47
PMID

Ferri GL, Isola J, Berger P, Giro G
Direct eye visualization of Cy5 fluorescence for immunocytochemistry and in situ hybridization.
J Histochem Cytochem 2000 ;48(3)437-44
PMID

Järvinen TA, Pelto-Huikko M, Holli K, Isola J
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
Am J Pathol 2000 ;156(1)29-35
PMID

Bruyere K, Bermond F, Bouquet R, Caire Y, Ramet M, Voiglio E
Human maxilla bone response to 30 degrees oriented impacts and comparison with frontal bone impacts.
Annu Proc Assoc Adv Automot Med 2000 ;44219-34
PMID

Ramet M, Haataja R, Marttila R, Hamalainen AM, Knip M, Hallman M
Human surfactant protein--A gene locus for genetic studies in the Finnish population.
Dis Markers 2000 ;16(3-4)119-24
PMID

Haataja R, Ramet M, Marttila R, Hallman M
Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome.
Hum Mol Genet 2000 ;9(18)2751-60
PMID

Ramet M, Haataja R, Marttila R, Floros J, Hallman M
Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population.
Am J Hum Genet 2000 ;66(5)1569-79
PMID

Manninen A, Renkema GH, Saksela K
Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway.
J Biol Chem 2000 ;275(22)16513-7
PMID

Renkema GH, Saksela K
Interactions of HIV-1 NEF with cellular signal transducing proteins.
Front Biosci 2000 ;5D268-83
PMID

Kajander OA, Rovio AT, Majamaa K, Poulton J, Spelbrink JN, Holt IJ, Karhunen PJ, Jacobs HT
Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states.
Hum Mol Genet 2000 ;9(19)2821-35
PMID

Juhola MK, Shah ZH, Grivell LA, Jacobs HT
The mitochondrial inner membrane AAA metalloprotease family in metazoans.
FEBS Lett 2000 ;481(2)91-5
PMID

Shah ZH, Hakkaart GA, Arku B, de Jong L, van der Spek H, Grivell LA, Jacobs HT
The human homologue of the yeast mitochondrial AAA metalloprotease Yme1p complements a yeast yme1 disruptant.
FEBS Lett 2000 ;478(3)267-70
PMID

Jacobs HT, Lehtinen SK, Spelbrink JN
No sex please, we're mitochondria: a hypothesis on the somatic unit of inheritance of mammalian mtDNA.
Bioessays 2000 ;22(6)564-72
PMID

Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, Lehtinen SK, Lecrenier N, Back JW, Speijer D, Foury F, Jacobs HT
In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells.
J Biol Chem 2000 ;275(32)24818-28
PMID

Holt IJ, Lorimer HE, Jacobs HT
Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA.
Cell 2000 ;100(5)515-24
PMID

Jacobs HT, Holt IJ
The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't.
Hum Mol Genet 2000 ;9(4)463-5
PMID

Lehtinen SK, Hance N, El Meziane A, Juhola MK, Juhola KM, Karhu R, Spelbrink JN, Holt IJ, Jacobs HT
Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA.
Genetics 2000 ;154(1)363-80
PMID

Desper R, Jiang F, Kallioniemi OP, Moch H, Papadimitriou CH, Schaffer AA
Distance-based reconstruction of tree models for oncogenesis.
J Comput Biol 2000 ;7(6)789-803
PMID

Wolf M, El-Rifai W, Tarkkanen M, Kononen J, Serra M, Eriksen EF, Elomaa I, Kallioniemi A, Kallioniemi OP, Knuutila S
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray.
Cancer Genet Cytogenet 2000 ;123(2)128-32
PMID

Schleutker J, Matikainen M, Smith J, Koivisto P, Baffoe-Bonnie A, Kainu T, Gillanders E, Sankila R, Pukkala E, Carpten J, Stephan D, Tammela T, Brownstein M, Bailey-Wilson J, Trent J, Kallioniemi OP
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
Clin Cancer Res 2000 ;6(12)4810-5
PMID

Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
Cancer Res 2000 ;60(23)6617-22
PMID

Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H
Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
Cancer Res 2000 ;60(22)6503-9
PMID

Mononen N, Syrjakoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.
Cancer Res 2000 ;60(22)6479-81
PMID

Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Cancer Res 2000 ;60(21)6111-5
PMID

Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
J Urol 2000 ;164(6)1992-5
PMID

Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjakoski K, Kainu T, Vahteristo P, Krahe R, Paakkonen K, Hartikainen J, Blomqvist C, Lopponen T, Holli K, Ryynanen M, Butzow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Eur J Hum Genet 2000 ;8(10)757-63
PMID

Matikainen MP, Sankila R, Schleutker J, Kallioniemi OP, Pukkala E
Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients.
Int J Cancer 2000 ;88(2)307-12
PMID

Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
J Natl Cancer Inst 2000 ;92(18)1529-31
PMID

Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.
Am J Pathol 2000 ;157(3)787-94
PMID

Forozan F, Mahlamaki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A, Kallioniemi OP
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Cancer Res 2000 ;60(16)4519-25
PMID

Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
Proc Natl Acad Sci U S A 2000 ;97(17)9603-8
PMID

Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
J Natl Cancer Inst 2000 ;92(15)1252-9
PMID

Eary JF, Krohn KA
Positron emission tomography: imaging tumor response.
Eur J Nucl Med 2000 ;27(12)1737-9
PMID

Krohn K, Frese P, Florke U
Biomimetic synthesis of the racemic angucyclinones of the aquayamycin and WP 3688-2 types.
Chemistry 2000 ;6(21)3887-96
PMID

Heitzer T, Krohn K, Albers S, Meinertz T
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.
Diabetologia 2000 ;43(11)1435-8
PMID

Hannula PM, Antonen JA, Saha HH, Koivisto AM, Krohn KJ, Pasternack AI
Constant, but not pulsed calcitriol suppresses hemodialysis patients' antigen-induced lymphocyte proliferation.
Nephron 2000 ;86(2)139-44
PMID

Krohn K, Wohlgemuth S, Gerber H, Paschke R
Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations.
J Pathol 2000 ;192(1)37-42
PMID

Heino M, Peterson P, Sillanpaa N, Guerin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Jenkinson EJ, Naquet P, Krohn KJ
RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse.
Eur J Immunol 2000 ;30(7)1884-93
PMID

Peterson P, Uibo R, Krohn KJ
Adrenal autoimmunity: results and developments.
Trends Endocrinol Metab 2000 ;11(7)285-90
PMID

Miedlich S, Krohn K, Lamesch P, Muller A, Paschke R
Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Eur J Endocrinol 2000 ;143(1)47-54
PMID

Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K, Antonarakis SE, Shimizu N, Kudoh J, Peterson P
Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family.
Genomics 2000 ;65(3)293-8
PMID

Reimand K, Peterson P, Hyoty H, Uibo R, Cooke I, Weetman AP, Krohn KJ
3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure.
J Clin Endocrinol Metab 2000 ;85(6)2324-6
PMID

Allen E, Krohn K
Adverse reaction to Hylan GF-20.
J Rheumatol 2000 ;27(6)1572
PMID

Krohn K, Bernhard S, Florke U, Hayat N
Biomimetic-type synthesis of benzo[a]naphthacenequinones related to pradimicinone.
J Org Chem 2000 ;65(10)3218-22
PMID

Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P
The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein.
J Biol Chem 2000 ;275(22)16802-9
PMID

Manninen A, Renkema GH, Saksela K
Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway.
J Biol Chem 2000 ;275(22)16513-7
PMID

Renkema GH, Saksela K
Interactions of HIV-1 NEF with cellular signal transducing proteins.
Front Biosci 2000 ;5D268-83
PMID

Pesu M, Takaluoma K, Aittomaki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O
Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
Blood 2000 ;95(2)494-502
PMID

Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ, Janne OA
ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.
Mol Endocrinol 2000 ;14(12)1986-2000
PMID

Ekman N, Arighi E, Rajantie I, Saharinen P, Ristimaki A, Silvennoinen O, Alitalo K
The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
Oncogene 2000 ;19(36)4151-8
PMID

Aittomaki S, Pesu M, Groner B, Janne OA, Palvimo JJ, Silvennoinen O
Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes.
J Immunol 2000 ;164(11)5689-97
PMID

Saharinen P, Takaluoma K, Silvennoinen O
Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.
Mol Cell Biol 2000 ;20(10)3387-95
PMID

Kovanen PE, Junttila I, Takaluoma K, Saharinen P, Valmu L, Li W, Silvennoinen O
Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells.
Blood 2000 ;95(5)1626-32
PMID

Paukku K, Valgeirsdottir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O
Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Biochem J 2000 ;345 Pt 3759-66
PMID

Pesu M, Takaluoma K, Aittomaki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O
Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
Blood 2000 ;95(2)494-502
PMID

Kajander OA, Rovio AT, Majamaa K, Poulton J, Spelbrink JN, Holt IJ, Karhunen PJ, Jacobs HT
Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states.
Hum Mol Genet 2000 ;9(19)2821-35
PMID

Jacobs HT, Lehtinen SK, Spelbrink JN
No sex please, we're mitochondria: a hypothesis on the somatic unit of inheritance of mammalian mtDNA.
Bioessays 2000 ;22(6)564-72
PMID

Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, Lehtinen SK, Lecrenier N, Back JW, Speijer D, Foury F, Jacobs HT
In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells.
J Biol Chem 2000 ;275(32)24818-28
PMID

Lehtinen SK, Hance N, El Meziane A, Juhola MK, Juhola KM, Karhu R, Spelbrink JN, Holt IJ, Jacobs HT
Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA.
Genetics 2000 ;154(1)363-80
PMID

Nupponen NN, Visakorpi T
Molecular cytogenetics of prostate cancer.
Microsc Res Tech 2000 ;51(5)456-63
PMID

Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
J Urol 2000 ;164(6)1992-5
PMID

Lindfors K, Halttunen T, Huotari P, Nupponen N, Vihinen M, Visakorpi T, Maki M, Kainulainen H
Identification of novel transcription factor-like gene from human intestinal cells.
Biochem Biophys Res Commun 2000 ;276(2)660-6
PMID

Hernes EH, Linja M, Fossa SD, Visakorpi T, Berner A, Winderen M, Koivisto PA
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.
BJU Int 2000 ;86(3)240-7
PMID

Koski T, Karhu R, Visakorpi T, Vilpo L, Knuutila S, Vilpo J
Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
Eur J Haematol 2000 ;65(1)32-9
PMID

Nupponen NN, Isola J, Visakorpi T
Mapping the amplification of EIF3S3 in breast and prostate cancer.
Genes Chromosomes Cancer 2000 ;28(2)203-10
PMID

 
Lääketieteen ja biotieteiden tiedekunta
Arvo Ylpön katu 34
33520 Tampere, Finland
Ylläpito: webmaster@biomeditech.fi
Muutettu: 12.8.2014 12.47 Muokkaa

Tampereen yliopisto

Tampereen yliopisto
03 355 111
kirjaamo@uta.fi


KARVI-auditoitu HR Excellence in Research

YLIOPISTO
Tutkimus
Opiskelijaksi
Ajankohtaista
Yhteistyö ja palvelut
Yliopisto

AJANKOHTAISTA
Aikalainen
Avoimet työpaikat
Rehtoriblogi
Tampere3

PALVELUT
Aktuaarinkanslia
Avoin yliopisto
Hallinto
Kansainvälisen koulutuksen keskus
Kielikeskus
Kielipalvelut
Kirjaamo
Kirjasto
Liikuntapalvelut
Viestintä
Tietohallinto
Tutkimuspalvelut
Täydennyskoulutus
Tietoarkisto
» lisää palveluita

OPISKELU
Opetusohjelma
Opinto-oppaat
Opiskelijan työpöytä

SÄHKÖISET PALVELUT
Andor-hakupalvelu
Uusi lainasi
Intra
Moodle (learning2)
NettiOpsu / NettiRekka
NettiKatti
Sähköinen tenttipalvelu
TamPub
Office 365 webmail
Utaposti webmail
Wentti